Michail_Petrov-96/iStock via Getty Images
Novo Nordisk (NVO) announced on Tuesday that it has submitted a new higher dose of its weight loss medication, Wegovy, to the European Medicines Agency for approval.
The company is requesting approval for a 7.2 mg dose of semaglutide, which adds